Results 161 to 170 of about 151,900 (300)

The Role of KRAS in Non-Small Cell Lung Cancer: From Molecular Background to Precision Medicine. [PDF]

Int J Mol Sci
Gaździcka J, Gołąbek K.
europepmc   +1 more source

Micro/Nanostructured Materials and Microfluidic Diagnostic Platforms Enable Multimodal Detection of Circulating Tumor Cells

Exploration, EarlyView.
Engineered micro/nanomaterials enable high‐efficiency CTC capture, release, and multimodal molecular profiling. Integrated with AI‐driven analytics, these platforms decode tumor heterogeneity and metastatic dynamics, advancing real‐time monitoring and precision oncology through DNA, RNA, and protein cross‐scale data fusion.
Hao Li, Jiaojiao Sun, Kunguo Liu, Shijie Wang, Bowen Fu, Hong Zhu, Peng Cao, Xin Han   +7 more
wiley   +1 more source

Advances in KRAS-Targeted Therapies for Pancreatic Cancer. [PDF]

Cancers (Basel)
Peshin S, Zahid A, Takrori E, Hamedi Z, Rahman S.   +4 more
europepmc   +1 more source

Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis

, 2018
Shi-Ming Zhang, Qing-Ge Zhu, Xiao-Xiao Ding, Song Lin, Jing Zhao, Lei Guan, Ting Li, Bing He, Hu-Qin Zhang The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi’an JiaoTong ...
Ding XX, Guan L, Lin S, Li T, Zhang HQ, Zhang SM, Zhu QG, Zhao J, He B   +8 more
core  

Extracellular vesicles derived from edible plants and edible fungi: Compositional characteristics, engineering strategies and biofunctions

Food Biomacromolecules, EarlyView.
Non‐animal extracellular vesicles as bioactive‐compound carriers: compositional characteristics, engineering strategies, and biofunctions. Abstract Animal‐derived extracellular vesicles (EVs) were widely used for bioactive compound delivery but constrained by complex origins, potential immunogenicity, and pathogen contamination.
Jiahao Yu, Rongheng Chen, Yuxuan Liu, Yizhen Xie, Fangyu Fan, Simin Feng, Ping Shao   +6 more
wiley   +1 more source

Rewiring KRAS-driven cancers through the ubiquitin-proteasome system: therapeutic opportunities with a focus on deubiquitinase. [PDF]

Exp Mol Med
Lee Y, Hwang S, Shin H, Choi K, Seo S, Kim H, Yang JS, Kim YJ, Kim YM, Song EJ.   +9 more
europepmc   +1 more source

Beyond Conventional PDOs: Organoids for Tumorigenesis for Gut Cancer Modeling and Fast Clinical Decision

Gut Medicine, EarlyView.
ABSTRACT Reproducing tumor biology in vivo using three‐dimensional organoids remains a debated topic in the cancer organoid field, despite the new FDA framework for evaluating cancer drugs with organoid models. Compared with patient‐derived organoids (PDOs), which offer a humanized model for testing cancer therapies, organoids derived from normal stem ...
Chong Gao
wiley   +1 more source

Dynamic Plasma KRAS ctDNA Profiling Identifies Treatment Response and Nascent Resistance in Metastatic Non-Small-Cell Lung Cancer: A Pilot Study. [PDF]

Cancers (Basel)
Buzzi V, Berti G, Santillo M, Belli A, Rosi E, Favarato G, Lavorini F, Tomassetti S, Arcangeli A, Iannopollo M, Lastraioli E.   +10 more
europepmc   +1 more source

J Cancer Res Ther (Manch) [PDF]

BackgroundIn 2011, the National Comprehensive Cancer Network (NCCN) recommended KRAS testing for metastatic colorectal cancer (mCRC) patients. Our study assessed KRAS testing prevalence and its association with socio-demographic and clinical factors and ...

core  

Experimental tests of a flywheel proof mass actuator for velocity feedback control

, 2018
Kras, A., Gardonio, P.
core   +1 more source